Combo of cancer therapy drugs increases mice lifespan by 30% — but anti-aging benefits in humans remain unknown
A cocktail of FDA-approved cancer drugs, trametinib and rapamycin, boosts the lifespan of lab mice by 30% and might help humans age better, new study finds.
A cocktail of FDA-approved cancer drugs, trametinib and rapamycin, boosts the lifespan of lab mice by 30% and might help humans age better, new study finds.
